141 related articles for article (PubMed ID: 22354537)
1. Clinical implications and prognostic significance of thrombocytopenia in Tunisian patients with systemic lupus erythematosus.
Jallouli M; Frigui M; Marzouk S; Snoussi M; Kechaou M; Kaddour N; Masmoudi H; Elloumi M; Bahloul Z
Lupus; 2012 May; 21(6):682-7. PubMed ID: 22354537
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis.
Zhao H; Li S; Yang R
Platelets; 2010; 21(5):380-5. PubMed ID: 20433308
[TBL] [Abstract][Full Text] [Related]
3. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
4. Clinical and immunological manifestations of systemic lupus erythematosus: study on 146 south Tunisian patients.
Jallouli M; Frigui M; Hmida MB; Marzouk S; Kaddour N; Bahloul Z
Saudi J Kidney Dis Transpl; 2008 Nov; 19(6):1001-8. PubMed ID: 18974596
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
[TBL] [Abstract][Full Text] [Related]
6. Lupus thrombocytopenia: clinical implications and prognostic significance.
Ziakas PD; Giannouli S; Zintzaras E; Tzioufas AG; Voulgarelis M
Ann Rheum Dis; 2005 Sep; 64(9):1366-9. PubMed ID: 16100344
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Miroshnichenko NG; Samokishina NA; Serova AG; Nesterova SG
Ter Arkh; 2006; 78(5):21-31. PubMed ID: 16889045
[TBL] [Abstract][Full Text] [Related]
8. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
Cook RJ; Gladman DD; Pericak D; Urowitz MB
J Rheumatol; 2000 Aug; 27(8):1892-5. PubMed ID: 10955329
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus.
Schmugge M; Revel-Vilk S; Hiraki L; Rand ML; Blanchette VS; Silverman ED
J Pediatr; 2003 Nov; 143(5):666-9. PubMed ID: 14615743
[TBL] [Abstract][Full Text] [Related]
10. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
[TBL] [Abstract][Full Text] [Related]
11. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
Laustrup H; Voss A; Green A; Junker P
Lupus; 2010 Mar; 19(3):239-46. PubMed ID: 19946037
[TBL] [Abstract][Full Text] [Related]
12. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
Fragoso-Loyo HE; Sánchez-Guerrero J
J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
Wang M; Gladman DD; Ibañez D; Urowitz MB
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
[TBL] [Abstract][Full Text] [Related]
14. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.
Drenkard C; Villa AR; Alarcón-Segovia D; Pérez-Vázquez ME
J Rheumatol; 1994 Jun; 21(6):1067-72. PubMed ID: 7932417
[TBL] [Abstract][Full Text] [Related]
15. Prognostic indicators of hospitalized patients with systemic lupus erythematosus: a large retrospective multicenter study in China.
Feng X; Zou Y; Pan W; Wang X; Wu M; Zhang M; Tao J; Zhang Y; Tan K; Li J; Chen Z; Ding X; Qian X; Da Z; Wang M; Sun L
J Rheumatol; 2011 Jul; 38(7):1289-95. PubMed ID: 21459949
[TBL] [Abstract][Full Text] [Related]
16. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
[TBL] [Abstract][Full Text] [Related]
17. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.
Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1995 Jul; 22(7):1265-70. PubMed ID: 7562756
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus and lupus syndromes in Senegal. A retrospective study of 30 patients seen over 10 years.
Ka MM; Diallo S; Kane A; Wade B; Diouf B; Diallo A; Moreira-Diop T
Rev Rhum Engl Ed; 1998; 65(7-9):471-6. PubMed ID: 9785393
[TBL] [Abstract][Full Text] [Related]
20. Familiality and co-occurrence of clinical features of systemic lupus erythematosus.
Tsao BP; Grossman JM; Riemekasten G; Strong N; Kalsi J; Wallace DJ; Chen CJ; Lau CS; Ginzler EM; Goldstein R; Kalunian KC; Harley JB; Arnett FC; Hahn BH; Cantor RM
Arthritis Rheum; 2002 Oct; 46(10):2678-85. PubMed ID: 12384927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
